Sharda Cropchem Q1 FY27 Agrochem Revenue Reaches Rs 915 Crore

Sharda Cropchem Limited reported agrochemical segment revenue of Rs 915 crore for the quarter ended June 30, 2026, an 8% year-on-year increase. Its non-agrochemical segment generated Rs 159 crore, up 15% year-on-year, according to the investor presentation submitted on July 29, 2026.

What did Sharda Cropchem report for Q1 FY27?

Sharda Cropchem reported revenue of Rs 915 crore from its agrochemical segment in Q1 FY27. The figure was 8% higher than the corresponding quarter of the previous year, based on the company's July 2026 investor presentation for the quarter ended June 30, 2026.

The non-agrochemical segment reported revenue of Rs 159 crore, marking year-on-year growth of 15%. The disclosed segment figures amount to Rs 1,074 crore, although the presentation excerpt identifies them separately as agrochemical and non-agrochemical revenue rather than specifying a consolidated revenue total.

The company made the presentation available to investors and analysts following its unaudited financial results for the June quarter. The filing was made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and the presentation was also placed on Sharda Cropchem's website under Regulation 46.

When was the Q1 FY27 presentation disclosed?

The Q1 FY27 investor presentation was disclosed on July 29, 2026, at 2:24 pm. It related to the quarter ended June 30, 2026, and accompanied the company's communication on unaudited financial results for that period.

Sharda Cropchem said the presentation was intended for investors and analysts. Its disclosure noted that the document was being uploaded in accordance with the listing regulations, providing shareholders and other market participants access to the quarterly business update.

The company's investor-relations page lists Q1 FY27 materials including an earnings conference call transcript, earnings conference call and investor presentation. This follows its established practice of publishing periodic presentations and call-related materials for quarterly results.

The supplied presentation material also includes references to older company presentations and financial updates. These historical documents should not be read as part of the Q1 FY27 performance announcement because they relate to separate reporting periods and market conditions.

How does Sharda Cropchem's asset-light model work?

Sharda Cropchem operates an asset-light model focused on identifying generic molecules, preparing dossiers, obtaining registrations, and marketing and distributing products. Manufacturing of active ingredients and formulations is outsourced, according to the company's presentation.

The company describes itself as an intellectual property-driven marketer and distributor of formulations and generic active ingredients. Its model uses third-party distributors and, where applicable, its own sales force to reach customers across its operating markets.

Registrations are a core element of this operating structure because they support the company's ability to market products in different jurisdictions. The company stated in the supplied material that it had procured 2,719 registrations, without specifying the reporting date for that figure in the Q1 FY27 excerpt.

The presentation identifies Europe, North America and Latin America as important advanced markets for the business. It also describes a diversified product offering across formulations and generic active ingredients, with crop-protection categories including fungicides, herbicides and insecticides cited in older company material.

Why do the segment revenue figures matter to investors?

The Q1 FY27 disclosure matters because it provides separate year-on-year growth rates for Sharda Cropchem's agrochemical and non-agrochemical operations. Agrochemicals remained the larger disclosed segment at Rs 915 crore, while the Rs 159 crore non-agrochemical segment recorded the faster percentage increase.

For investors, the segment split helps distinguish the performance of the core crop-protection business from the company's non-agrochemical activities. The company has previously described its non-agrochemical business as order-based procurement and supply of products such as conveyor belts, general chemicals, dyes and dye intermediates.

The revenue update does not include information in the supplied text on profit, margins, volumes, pricing, regional sales or cash flow for Q1 FY27. As a result, the disclosed figures establish revenue movement by segment but do not independently explain the factors behind growth or the effect on profitability.

The presentation also does not provide a share-price reaction or a market forecast. Any assessment of the stock-market implications would therefore require information beyond this filing, including the full financial results and investor-call discussion.

Conclusion

Sharda Cropchem's Q1 FY27 presentation reported 8% year-on-year growth in agrochemical revenue to Rs 915 crore and 15% growth in non-agrochemical revenue to Rs 159 crore. The update highlights continued reporting of its two operating segments and the central role of its registration-led, outsourced-manufacturing business model.

The next scheduled source of detail is the company's Q1 FY27 earnings conference call material, including the transcript listed on its investor-relations page. Investors will be able to review those disclosures alongside the full unaudited financial results for information on profitability, market conditions and business operations not included in the presentation excerpt.